Atherosclerosis: Diet and Drugs
Cardiovascular diseases continue to be the leading cause of death in the - jority of industrialized countries. The most frequent underlying pathology, namely atherosclerosis, and its clinical sequelae, namely coronary heart d- ease, cerebrovascular disease and peripheral artery disease, remain commo...
Other Authors: | |
---|---|
Format: | eBook |
Language: | English |
Published: |
Berlin, Heidelberg
Springer Berlin Heidelberg
2005, 2005
|
Edition: | 1st ed. 2005 |
Series: | Handbook of Experimental Pharmacology
|
Subjects: | |
Online Access: | |
Collection: | Springer eBooks 2005- - Collection details see MPG.ReNa |
Table of Contents:
- Background
- The Pathogenesis of Atherosclerosis
- Risk Factors for Atherosclerotic Vascular Disease
- Metabolic Syndrome: Therapeutic Considerations
- The Impact of Diet
- Physical Activity, Obesity and Cardiovascular Diseases
- Fatty Acids and Atherosclerotic Risk
- Dietary Cholesterol, Atherosclerosis and Coronary Heart Disease
- Plant Sterols and Stanols
- Carbohydrates and Dietary Fiber
- Dietary Antioxidants and Paraoxonases Against LDL Oxidation and Atherosclerosis Development
- Soy, Isoflavones and Atherosclerosis
- Homocysteine and B Vitamins
- Alcohol
- Evidence-Based Anti-Atherosclerotic Drug Therapy
- Lipid and Non-lipid Effects of Statins
- Fibrates
- ACE Inhibitors and Angiotensin II Receptor Antagonists
- Inhibition of Platelet Activation and Aggregation
- Targets of Future Anti-Atherosclerotic Drug Therapy
- The ABC of Hepatic and Intestinal Cholesterol Transport
- Inhibition of the Synthesis of Apolipoprotein B-Containing Lipoproteins
- Therapy of Hyper-Lp(a)
- Modulation of High-Density Lipoprotein Cholesterol Metabolism and Reverse Cholesterol Transport
- Inhibition of Lipoprotein Lipid Oxidation
- Correction of Insulin Resistance and the Metabolic Syndrome
- Protection of Endothelial Function
- Modulation of Smooth Muscle Cell Proliferation and Migration: Role of Smooth Muscle Cell Heterogeneity
- Modulation of Macrophage Function and Metabolism
- Inflammation Is a Crucial Feature of Atherosclerosis and a Potential Target to Reduce Cardiovascular Events
- Autoimmune Mechanisms of Atherosclerosis
- Drug Therapies to Prevent Coronary Plaque Rupture and Erosion: Present and Future
- Reciprocal Role of Vasculogenic Factors and Progenitor Cells in Atherogenesis
- Gene Therapy of Atherosclerosis